# Tempest Therapeutics, Inc.: Form 8-K, filed May 10, 2023

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2023-05-10
- Accepted by EDGAR: May 10, 2023, 16:21 ET
- Period: 2023-05-10
- Accession: 0000950170-23-020569
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000095017023020569/tpst-20230510.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000095017023020569/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000095017023020569/tpst-20230510.htm

Filed May 10, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-020569. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
